Jeff has more than seven years of experience in life sciences consulting with the focus on client strategy from drug discovery and development through commercialization.
Prior to joining Bluestar, Jeff was an Associate Director in the Life Sciences Practice at Navigant/Guidehouse, where he led or conducted over 100 engagements with pharma and biotech clients. Jeff specializes in market opportunity assessment, due diligence of licensing and acquisition targets, asset and portfolio valuation, and competitive intelligence. Additionally, Jeff has extensive therapeutic area experience in nephrology and cardiology, as well as rare, genetically-defined diseases and cancers.
Jeff holds a PhD in Physiology and Biophysics from Thomas Jefferson University, and a BS in Applied Mathematics from Columbia University.